{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:41:21Z","timestamp":1793032881312,"version":"4.5.0"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014538","name":"Lembaga Pengelola Dana Pendidikan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100643","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:29:37Z","timestamp":1787182177000},"page":"100643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeted Nanoparticle Delivery CRISPR\/Cas9: overcoming biological barriers, enhancing stability, and improving therapeutic precision"],"prefix":"10.1016","volume":"12","author":[{"given":"Sriwidodo","family":"Sriwidodo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecep","family":"Suhandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salsa","family":"Sagitasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belva Annora Alfita","family":"Davinali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman Permana","family":"Maksum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabreena","family":"Safuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100643_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202411359","article-title":"Synthetic Aspects and Characterization Needs in MOF Chemistry \u2013 from Discovery to Applications","author":"Achenbach","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijpx.2026.100643_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107482","article-title":"Delayed nuclear localization of CRISPR\/Cas9-modified fiber of fowl adenovirus serotype 8b reduces pathogenicity in Specific pathogen-free chicken embryonic liver cells","volume":"203","author":"Ahmed","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijpx.2026.100643_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2025.199682","article-title":"Optimization of lipid nanoparticles loaded with ribonucleoprotein-oligonucleotide complexes for in vivo delivery of a CRISPR\/Cas9 system targeting hepatitis B virus","volume":"363","author":"Akhter","year":"2026","journal-title":"Virus Res."},{"key":"10.1016\/j.ijpx.2026.100643_bb0020","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.0c16380","article-title":"Spatial and Temporal Control of CRISPR-Cas9-Mediated Gene Editing Delivered via a Light-Triggered Liposome System","volume":"12","author":"Aksoy","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpx.2026.100643_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.102910","article-title":"Influence of nanoparticles surface coating on physicochemical properties for CRISPR gene delivery","volume":"66","author":"Alallam","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41592-021-01328-8","article-title":"Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4+ T cells allows complex functional analyses","volume":"19","author":"Albanese","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ijpx.2026.100643_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136070","article-title":"GSH\/pH-Responsive Chitosan\u2013PLA Hybrid Nanosystems for Targeted Ledipasvir Delivery to HepG2 Cells: Controlled Release, Improved Selectivity, DNA Interaction, Electrochemical and Stopped-Flow Kinetics Analyses","volume":"26","author":"Albasiony","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42013","article-title":"New frontiers in CRISPR: Addressing antimicrobial resistance with Cas9, Cas12, Cas13, and Cas14","author":"Ali Agha","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.ijpx.2026.100643_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29245997","article-title":"Endosomal Escape and Nuclear Localization: Critical Barriers for Therapeutic Nucleic Acids","author":"Allen","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ijpx.2026.100643_bb0050","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.7b11754","article-title":"Endosomal Escape and Delivery of CRISPR\/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework","volume":"140","author":"Alsaiari","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpx.2026.100643_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110682","article-title":"Efficient Delivery of CRISPR-Cas9 RNP Complexes with Cyclodextrin-Based Nanosponges for Enhanced Genome Editing: TILD-CRISPR Integration","volume":"26","author":"Amiri","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0060","doi-asserted-by":"crossref","DOI":"10.52225\/narra.v3i2.184","article-title":"Application of CRISPR-Cas9 genome editing technology in various fields: A review","author":"Ansori","year":"2023","journal-title":"Narra J."},{"key":"10.1016\/j.ijpx.2026.100643_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101585","article-title":"Design of cationic ionizable lipids for the delivery of therapeutic nucleic acids","author":"Atmuri","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ijpx.2026.100643_bb0070","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160616","article-title":"Cytoplasmic transport and nuclear import of plasmid DNA","author":"Bai","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ijpx.2026.100643_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/17435889.2025.2571024","article-title":"Innate immuno-response to nanoparticle uptake in liver and spleen mimics pathogen infection","volume":"20","author":"Brodin","year":"2025","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100643_bb0080","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2025017321","article-title":"Comparative analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model","volume":"10","author":"Butt","year":"2026","journal-title":"Blood Adv."},{"key":"10.1016\/j.ijpx.2026.100643_bb0085","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.5c18112","article-title":"The Biology of Endosomal Escape: Strategies for Enhanced Delivery of Therapeutics","volume":"20","author":"Chahal","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100643_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110828","article-title":"Layer-by-layer coated chitosan-CRISPR\/Cas9 mTOR nanoparticles: A novel approach to inhibit lens epithelial cell proliferation and migration for preventing posterior capsule opacification","volume":"264","author":"Chang","year":"2026","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpx.2026.100643_bb0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: A bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijpx.2026.100643_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/biomimetics7030126","article-title":"Harnessing Protein Corona for Biomimetic Nanomedicine Design","author":"Chen","year":"2022","journal-title":"Biomimetics"},{"key":"10.1016\/j.ijpx.2026.100643_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-024-02437-3","article-title":"Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR\u2013Cas9 ribonucleoprotein","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101649","article-title":"Crispr\/cas9 delivery system engineering for genome editing in therapeutic applications","author":"Cheng","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100643_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2024.07.001","article-title":"In vivo genome editing for inherited retinal disease: Opportunities and challenges","author":"Collin","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpx.2026.100643_bb0120","article-title":"Carrier-free cellular transport of crispr\/cas9 ribonucleoprotein for genome editing by cold atmospheric plasma","volume":"10","author":"Cui","year":"2021","journal-title":"Biol.-Basel"},{"key":"10.1016\/j.ijpx.2026.100643_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202500242","article-title":"Nonviral Gold Nanoparticle-Mediated Delivery of CRISPR-Cas9 Ribonucleoprotein and Long DNA Transgenes Into Primary Blood Cells","author":"Cunningham","year":"2026","journal-title":"Adv. Nanobiomed Res. n\/a"},{"key":"10.1016\/j.ijpx.2026.100643_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17387-x","article-title":"CRISPR\/Cas9 mediated mutation of mouse IL-1\u03b1 nuclear localisation sequence abolishes expression","volume":"7","author":"Daniels","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2026.100643_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-021-01942-4","article-title":"Efficacy and long-term safety of CRISPR\/Cas9 genome editing in the SOD1-linked mouse models of ALS","volume":"4","author":"Deng","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0145","doi-asserted-by":"crossref","DOI":"10.1261\/rna.079507.122","article-title":"Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?","volume":"29","author":"Dowdy","year":"2023","journal-title":"RNA"},{"key":"10.1016\/j.ijpx.2026.100643_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/nano11112991","article-title":"The interactions between nanoparticles and the innate immune system from a nanotechnologist perspective","author":"Ernst","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijpx.2026.100643_bb0155","series-title":"Activation of toll-like receptors by non-coding RNAs and their fragments (Review)","author":"Esparza-Garrido","year":"2025"},{"key":"10.1016\/j.ijpx.2026.100643_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1645657","article-title":"Functionalized metal-organic framework and MOF-derived materials for bone regeneration applications","author":"Fan","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.117215","article-title":"Lysosome toxicities induced by nanoparticle exposure and related mechanisms","author":"Feng","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.ijpx.2026.100643_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2025.04.095","article-title":"\u2020 VERVE-102, a clinical stage in vivo base editing medicine, leads to potent and precise inactivation of PCSK9 in preclinical studies","volume":"19","author":"Flight","year":"2025","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.ijpx.2026.100643_bib856","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102488","article-title":"Systemic biodistribution and hepatocyte-specific gene editing with CRISPR\/Cas9 using hyaluronic acid-based nanoparticles","volume":"40","author":"Francis","year":"2022","journal-title":"Nanomed"},{"key":"10.1016\/j.ijpx.2026.100643_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/bios14020067","article-title":"Hybrid Nanomaterials: A Brief Overview of Versatile Solutions for Sensor Technology in Healthcare and Environmental Applications","author":"Godja","year":"2024","journal-title":"Biosensors (Basel)."},{"key":"10.1016\/j.ijpx.2026.100643_bb0180","article-title":"Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform","author":"Guo","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpx.2026.100643_bb0185","article-title":"The Importance of Genetic Diagnosis in Rare Diseases. Balkan","author":"G\u00fcrkan","year":"2025","journal-title":"Med. J."},{"key":"10.1016\/j.ijpx.2026.100643_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2024.11.008","article-title":"Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based nanoparticles for efficient in vitro and in vivo applications","volume":"376","author":"Guzman Gonzalez","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100643_bb0195","doi-asserted-by":"crossref","DOI":"10.20517\/evcna.2024.19","article-title":"Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design","author":"Hagedorn","year":"2024","journal-title":"Extracell. Vesicles Circ. Nucl. Acids."},{"key":"10.1016\/j.ijpx.2026.100643_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02972-w","article-title":"Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach","author":"Haghighi","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26830-7","article-title":"Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models","volume":"12","author":"Hakim","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2026.100643_bb0210","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad676","article-title":"Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR\/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification","volume":"51","author":"Haldrup","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpx.2026.100643_bb0215","doi-asserted-by":"crossref","DOI":"10.1007\/s00109-020-01893-z","article-title":"Mitigating off-target effects in CRISPR\/Cas9-mediated in vivo gene editing","author":"Han","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijpx.2026.100643_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211121","article-title":"Nanomaterials in Drug Delivery: Leveraging Artificial Intelligence and Big Data for Predictive Design","author":"Han","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0225","article-title":"Active Intracellular Delivery of a Cas9\/sgRNA Complex Using Ultrasound-Propelled Nanomotors","volume":"57","author":"Hansen-Bruhn","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ijpx.2026.100643_bb0230","doi-asserted-by":"crossref","DOI":"10.1080\/17425247.2024.2375400","article-title":"Understanding nanoparticle-liver interactions in nanomedicine","author":"He","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100643_bb0235","doi-asserted-by":"crossref","DOI":"10.1007\/s12033-022-00567-0","article-title":"A Review on the Mechanism and Applications of CRISPR\/Cas9\/Cas12\/Cas13\/Cas14 Proteins Utilized for Genome Engineering","author":"Hillary","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0240","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S199104","article-title":"Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by crispr-cas9","volume":"14","author":"Hosseini","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100643_bb0245","doi-asserted-by":"crossref","DOI":"10.1007\/s40291-024-00696-z","article-title":"Exagamglogene Autotemcel: First Approval","volume":"28","author":"Hoy","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.ijpx.2026.100643_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114499","article-title":"Lipid nanoparticle-mediated CRISPR\/Cas9 delivery enables efficient trabecular meshwork gene editing in mice","volume":"389","author":"Huang","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100643_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02427-2","article-title":"Finely tuned ionizable lipid nanoparticles for CRISPR\/Cas9 ribonucleoprotein delivery and gene editing","volume":"22","author":"Im","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0260","article-title":"Nanoparticle technologies in precision oncology and personalized vaccine development: Challenges and advances","author":"Imani","year":"2025","journal-title":"Int. J. Pharm. X."},{"key":"10.1016\/j.ijpx.2026.100643_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102733","article-title":"Precision gene editing: The power of CRISPR-Cas in modern genetics","author":"Joo","year":"2025","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.ijpx.2026.100643_bb0270","doi-asserted-by":"crossref","DOI":"10.1007\/s12672-024-01195-7","article-title":"Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy","author":"Joshi","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-026-03022-6","article-title":"In vivo endosomal escape assay identifies mechanisms for efficient hepatic LNP delivery","author":"Jozi\u0107","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102636","article-title":"Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges","author":"Kalter","year":"2025","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.ijpx.2026.100643_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2023.07.013","article-title":"Biophysical characterization of siRNA-loaded lipid nanoparticles with different PEG content in an aqueous system","volume":"190","author":"Kim","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100643_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114635","article-title":"Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery","author":"Kim","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100643_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00424-9","article-title":"Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial","volume":"24","author":"Kim","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpx.2026.100643_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17101309","article-title":"Physiological Barriers to Nucleic Acid Therapeutics and Engineering Strategies for Lipid Nanoparticle Design, Optimization, and Clinical Translation","author":"Kim","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100643_bb0305","article-title":"FAST-CRISPR: Fusogenic Association and Secured Transfection of CRISPR\/Cas9 Ribonucleoproteins Using Lipid-Silica Hybrid Nanoparticles for Therapeutic Genome Editing","volume":"22","author":"Kim","year":"2026","journal-title":"Small"},{"key":"10.1016\/j.ijpx.2026.100643_bb0310","doi-asserted-by":"crossref","DOI":"10.1055\/s-0044-1785234","article-title":"CRISPR\u2013Cas9 Gene Editing: Curing Genetic Diseases by Inherited Epigenetic Modifications","volume":"11","author":"Kolanu","year":"2024","journal-title":"Glob. Med. Genet."},{"key":"10.1016\/j.ijpx.2026.100643_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17030379","article-title":"Clinical Applications of Targeted Nanomaterials","author":"Kumar","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100643_bb0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-33092-4","article-title":"Lipid-coated mesoporous silica nanoparticles for anti-viral applications via delivery of CRISPR-Cas9 ribonucleoproteins","volume":"13","author":"LaBauve","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2026.100643_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-017-0137-2","article-title":"Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair","volume":"1","author":"Lee","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ijpx.2026.100643_bb0330","doi-asserted-by":"crossref","DOI":"10.3171\/2019.4.JNS181761","article-title":"Current and future directions of deep brain stimulation for neurological and psychiatric disorders","author":"Lee","year":"2019","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ijpx.2026.100643_bb0335","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.122.062132","article-title":"Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models","volume":"147","author":"Lee","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ijpx.2026.100643_bb0340","article-title":"CRISPR-Cas9 Gene Therapy: Non-Viral Delivery and Stimuli-Responsive Nanoformulations","author":"Lee","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ijpx.2026.100643_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.gimo.2024.101875","volume":"2","author":"Lesmana","year":"2024","journal-title":"Genetics in Med. Open"},{"key":"10.1016\/j.ijpx.2026.100643_bb0350","article-title":"Intracellular delivery and biodistribution study of CRISPR\/Cas9 ribonucleoprotein loaded bioreducible lipidoid nanoparticles","volume":"7","author":"Li","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0355","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.9b17598","article-title":"Biomimetic Mineralization-Based CRISPR\/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing","volume":"11","author":"Li","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpx.2026.100643_bb0360","article-title":"Gene and RNA Editing: Revolutionary Approaches to Treating Diseases","author":"Li","year":"2025","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.ijpx.2026.100643_bb0365","article-title":"Design Strategies for Novel Lipid Nanoparticle for mRNA Vaccine and Therapeutics: Current Understandings and Future Perspectives","author":"Li","year":"2025","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.ijpx.2026.100643_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2025.101262","article-title":"Discovering the nuclear localization signal universe through a deep learning model with interpretable attention units","volume":"6","author":"Li","year":"2025","journal-title":"Patterns"},{"key":"10.1016\/j.ijpx.2026.100643_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102344","article-title":"CRISPR-Cas9-mediated homology-directed repair for precise gene editing","author":"Liao","year":"2024","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.ijpx.2026.100643_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114542","article-title":"Aptamer-functionalized nanoparticles for CRISPR-Cas9 delivery to circulating malignant cells for therapeutic efficacy evaluation","volume":"390","author":"Liao","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100643_bb0385","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24179","article-title":"CRISPR\/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials","volume":"6","author":"Lin","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ijpx.2026.100643_bb0390","article-title":"PH-Responsive poly(D,L-lactic-co-glycolic acid) nanoparticles with rapid antigen release behavior promote immune response","volume":"9","author":"Liu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100643_bb0395","doi-asserted-by":"crossref","DOI":"10.1039\/C8BM00263K","article-title":"Systemic delivery of CRISPR\/Cas9 with PEG-PLGA nanoparticles for chronic myeloid leukemia targeted therapy","volume":"6","author":"Liu","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0400","doi-asserted-by":"crossref","DOI":"10.1038\/s41563-020-00886-0","article-title":"Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR\u2013Cas gene editing","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ijpx.2026.100643_bb0405","article-title":"Translation efficiency covariation across cell types is a conserved organizing principle of mammalian transcriptomes","author":"Liu","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ijpx.2026.100643_bb0410","doi-asserted-by":"crossref","DOI":"10.1007\/s12272-024-01514-0","article-title":"Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition","volume":"47","author":"Lo","year":"2024","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijpx.2026.100643_bb0415","article-title":"Correction of RNA splicing defect in \u03b2654-thalassemia mice using CRISPR\/Cas9 gene-editing technology","volume":"107","author":"Lu","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.ijpx.2026.100643_bb0420","doi-asserted-by":"crossref","DOI":"10.1080\/17425247.2018.1517746","article-title":"Delivery approaches for CRISPR\/Cas9 therapeutics in vivo: advances and challenges","author":"Luther","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100643_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/biom15081132","article-title":"Improving the Efficiency of CRISPR\/Cas9-Mediated Non-Homologous End Joining Gene Knockout Using Small Molecules in Porcine Cells","volume":"15","author":"Lv","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijpx.2026.100643_bb0430","article-title":"High-throughput assays to assess variant effects on disease","volume":"17","author":"Ma","year":"2024","journal-title":"DMM Disease Models Mechanisms"},{"key":"10.1016\/j.ijpx.2026.100643_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ph18060864","article-title":"Engineering Lipid\u2013Polymer Nanoparticles for siRNA Delivery to Cancer Cells","volume":"18","author":"Manda","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpx.2026.100643_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114607","article-title":"Optimized lipid nanoparticles for pulmonary delivery of CRISPR\/Cas9 targeting KRAS G12S in lung cancer","volume":"391","author":"Marschhofer","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100643_bb0445","article-title":"Mixing and flow-induced nanoprecipitation for morphology control of silk fibroin self-assembly","volume":"12","author":"Matthew","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpx.2026.100643_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.147792","article-title":"Recent advances in polysaccharide-derived piezoelectric nanogenerators for wound healing application","author":"Mehnath","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0455","doi-asserted-by":"crossref","DOI":"10.1093\/jpp\/rgaf127","article-title":"Engineering stimuli-responsive nanocarriers for CRISPR\/Cas9 genome editing: next-generation cancer therapeutics","author":"Mehnath","year":"2026","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0460","article-title":"Bone-Adhesive Hydrogel for Effective Inhibition of M. tuberculosis and Osteoblast Regeneration. ACS","volume":"9","author":"Mehnath","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.ijpx.2026.100643_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.1075","article-title":"A dimethylmaleic acid - Melittin-polylysine conjugate with reduced toxicity, pH-triggered endosomolytic activity and enhanced gene transfer potential","volume":"9","author":"Meyer","year":"2007","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ijpx.2026.100643_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310623","article-title":"Comparative Study of Nanoparticle Blood Circulation after Forced Clearance of Own Erythrocytes (Mononuclear Phagocyte System-Cytoblockade) or Administration of Cytotoxic Doxorubicin- or Clodronate-Loaded Liposomes","volume":"24","author":"Mochalova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303134","article-title":"In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR\/Cas9 Editing System in Mice Unveil Histopathology of Pten\/p53-Deficient Endometrial Cancers","volume":"10","author":"Navaridas","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102318","article-title":"Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles","volume":"35","author":"Nielsen","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ijpx.2026.100643_bb0485","doi-asserted-by":"crossref","DOI":"10.1089\/crispr.2024.0080","article-title":"Hairpin Internal Nuclear Localization Signals in CRISPR-Cas9 Enhance Editing in Primary Human Lymphocytes","volume":"8","author":"Noel","year":"2025","journal-title":"CRISPR J."},{"key":"10.1016\/j.ijpx.2026.100643_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/nano16040268","article-title":"Identifying Key Factors Affecting mRNA-Lipid Nanoparticles Drug Product Formulation Stability","volume":"16","author":"Nomani","year":"2026","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijpx.2026.100643_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2020.07.027","article-title":"Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery","volume":"114","author":"Noureddine","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2026.100643_bb0500","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq3010","article-title":"Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia","volume":"14","author":"Ottaviano","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijpx.2026.100643_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112308","article-title":"The effects of surface functionality and size of gold nanoparticles on neuronal toxicity, apoptosis, ROS production and cellular\/suborgan biodistribution","volume":"128","author":"Ozcicek","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijpx.2026.100643_bb0510","article-title":"A Recent Update: Solid Lipid Nanoparticles for Effective Drug Delivery","author":"Pandey","year":"2022","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ijpx.2026.100643_bb0515","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene Editing for CEP290 -Associated Retinal Degeneration","volume":"390","author":"Pierce","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpx.2026.100643_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2022.11.009","article-title":"Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer","volume":"352","author":"Rajana","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100643_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultsonch.2025.107567","article-title":"Controlled localization of ultrasound heating using magnetic nanoparticle assemblies","volume":"121","author":"Ratajczak","year":"2025","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.ijpx.2026.100643_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/cells14151136","article-title":"Nanotechnology-Based Delivery of CRISPR\/Cas9 for Cancer Treatment: A Comprehensive Review","author":"Rauf","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ijpx.2026.100643_bb0535","doi-asserted-by":"crossref","DOI":"10.3762\/bjoc.17.75","article-title":"Enhanced target cell specificity and uptake of lipid nanoparticles using RNA aptamers and peptides","volume":"17","author":"Ray","year":"2021","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ijpx.2026.100643_bb0540","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-61465-6","article-title":"Polyethylenimine based magnetic nanoparticles mediated non-viral CRISPR\/Cas9 system for genome editing","volume":"10","author":"Rohiwal","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2026.100643_bb0545","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0703778104","article-title":"Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes","volume":"104","author":"Rozema","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijpx.2026.100643_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119736","article-title":"Ultrasound-activated particles as CRISPR\/Cas9 delivery system for androgenic alopecia therapy","volume":"232","author":"Ryu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpx.2026.100643_bb0555","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-20-0581","article-title":"Inhibition of nuclear pore complex formation selectively induces cancer cell death","volume":"11","author":"Sakuma","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ijpx.2026.100643_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2017.07.014","article-title":"Contribution of Kupffer cells to liposome accumulation in the liver","volume":"158","author":"Samuelsson","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpx.2026.100643_bb0565","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402259","article-title":"A Multifunctional Aptamer Decorated Lipid Nanoparticles for the Delivery of EpCAM-targeted CRISPR\/Cas9 Plasmid for Efficacious In Vivo Tumor Regression","volume":"13","author":"Sarkar","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijpx.2026.100643_bb0570","doi-asserted-by":"crossref","DOI":"10.1021\/acs.nanolett.3c05057","article-title":"A Scalable Microfluidic Platform for Nanoparticle Formulation: For Exploratory- and Industrial-Level Scales","volume":"24","author":"Seder","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijpx.2026.100643_bb0575","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26094420","article-title":"CRISPR\/Cas9 Delivery Systems to Enhance Gene Editing Efficiency","author":"Seijas","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0580","doi-asserted-by":"crossref","DOI":"10.1039\/D3LC01097J","article-title":"Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals","author":"Sharma","year":"2024","journal-title":"Lab Chip"},{"key":"10.1016\/j.ijpx.2026.100643_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: Immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100643_bb0590","article-title":"The Power of Clinical Diagnosis for Deciphering Complex Genetic Mechanisms in Rare Diseases","author":"Shu","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ijpx.2026.100643_bb0595","doi-asserted-by":"crossref","DOI":"10.1007\/s13534-021-00199-4","article-title":"Challenges in delivery systems for CRISPR-based genome editing and opportunities of nanomedicine","author":"Sioson","year":"2021","journal-title":"Biomed. Eng. Lett."},{"key":"10.1016\/j.ijpx.2026.100643_bb0600","doi-asserted-by":"crossref","DOI":"10.3168\/jds.2020-19901","article-title":"Single-plasmid systems based on CRISPR-Cas9 for gene editing in Lactococcus lactis","volume":"104","author":"Song","year":"2021","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444437","article-title":"Advances in delivery systems for CRISPR\/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles","author":"Song","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0610","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.5c06230","article-title":"A Molecular Glue Approach to Control the Half-Life of CRISPR-Based Technologies","volume":"147","author":"Sreekanth","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpx.2026.100643_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2025.06.045","article-title":"Peeling back the layers of immunogenicity in Cas9-based genomic medicine","author":"Stigzelius","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpx.2026.100643_bb0620","doi-asserted-by":"crossref","DOI":"10.1039\/D4NR04762A","article-title":"Non-nuclear localization signal-guided CRISPR\/Cas9 ribonucleoproteins for translocation and gene editing via apoferritin delivery vectors","volume":"17","author":"Sun","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijpx.2026.100643_bb0625","doi-asserted-by":"crossref","DOI":"10.1007\/s12195-023-00784-w","article-title":"Nuclear Entry of DNA and Transgene Expression in Dividing and Non-dividing Cells","volume":"16","author":"Sylvers","year":"2023","journal-title":"Cell. Mol. Bioeng."},{"key":"10.1016\/j.ijpx.2026.100643_bb0630","doi-asserted-by":"crossref","DOI":"10.1186\/s44301-025-00014-4","article-title":"Beyond PEGylation: nanoparticle surface modulation for enhanced cancer therapy","volume":"1","author":"Taghavimandi","year":"2025","journal-title":"Health Nanotechnol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0635","doi-asserted-by":"crossref","DOI":"10.1080\/17435889.2025.2598331","article-title":"Advances in the applications of stimulus-responsive nanomedicines for anti-cancer therapy","author":"Tan","year":"2026","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100643_bb0640","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.9b17749","article-title":"Cell-Selective Messenger RNA Delivery and CRISPR\/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid","volume":"11","author":"Tang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpx.2026.100643_bb0645","doi-asserted-by":"crossref","DOI":"10.7150\/ijms.112724","article-title":"Overcoming the Delivery Challenges in CRISPR\/Cas9 Gene Editing for Effective Cancer Treatment: A Review of Delivery Systems","author":"Tang","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104628","article-title":"Fabrication and evaluation of a dual-targeting nanoparticle mediated CRISPR\/Cas9 delivery to combat drug resistance in breast cancer cells","volume":"86","author":"Tavazohi","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0655","doi-asserted-by":"crossref","DOI":"10.1089\/crispr.2020.0025","article-title":"Translating CRISPR-Cas Therapeutics: Approaches and Challenges","author":"Tay","year":"2020","journal-title":"CRISPR J."},{"key":"10.1016\/j.ijpx.2026.100643_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2020.03.015","article-title":"Variability in Genome Editing Outcomes: Challenges for Research Reproducibility and Clinical Safety","author":"Teboul","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpx.2026.100643_bb0665","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23997-x","article-title":"Unravelling cytosolic delivery of cell penetrating peptides with a quantitative endosomal escape assay","volume":"12","author":"Teo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2026.100643_bb0670","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.17768","article-title":"Effect of rapamycin on lysosomal accumulation in a CRISPR\/Cas9-based cellular model of VPS13A deficiency","volume":"27","author":"Tornero-\u00c9cija","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijpx.2026.100643_bb0675","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.31.3.030901","article-title":"Medical hyperspectral imaging: an updated review of technology advancements and biomedical applications","volume":"31","author":"Tran","year":"2026","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.ijpx.2026.100643_bb0680","article-title":"Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity","author":"Tripathi","year":"2025","journal-title":"BioImpacts"},{"key":"10.1016\/j.ijpx.2026.100643_bb0685","doi-asserted-by":"crossref","DOI":"10.1161\/circ.150.suppl_1.4139206","article-title":"Abstract 4139206: Design of Heart-2: a phase 1b clinical trial of VERVE-102, an in vivo base editing medicine delivered by a GalNAc-LNP and targeting PCSK9 to durably lower LDL cholesterol","volume":"150","author":"Vafai","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ijpx.2026.100643_bb0690","article-title":"Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijpx.2026.100643_bb0695","article-title":"Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy","volume":"57","author":"Wang","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ijpx.2026.100643_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2020.04.052","article-title":"A pH-responsive silica\u2013metal\u2013organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries","volume":"324","author":"Wang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100643_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25215210","article-title":"Biomimetic Alginate\/Gelatin Cross-Linked Hydrogels Supplemented with Polyphosphate for Wound Healing Applications","volume":"25","author":"Wang","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijpx.2026.100643_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2021.06.030","article-title":"In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles","volume":"336","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100643_bb0715","article-title":"CRISPR\/Cas9 delivery by NIR-responsive biomimetic nanoparticles for targeted HBV therapy","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0720","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12101148","article-title":"Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery","author":"Wang","year":"2024","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.ijpx.2026.100643_bb0725","article-title":"Low-liver-accumulation lipid nanoparticles enhance the efficacy and safety of HPV therapeutic tumor vaccines","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijpx.2026.100643_bb0730","doi-asserted-by":"crossref","DOI":"10.1002\/biot.70146","article-title":"mRNA Stability: An Unresolved Challenge for Broad Therapeutic Applications","author":"Wang","year":"2025","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ijpx.2026.100643_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102737","article-title":"Unlocking mRNA-driven CRISPR-Cas9 gene therapy via optimizing mRNA and the delivery vectors","author":"Wang","year":"2025","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.ijpx.2026.100643_bb0740","doi-asserted-by":"crossref","DOI":"10.1186\/s11671-025-04316-5","article-title":"Efficient encapsulation of CRISPR-Cas9 RNP in bioreducible nanogels and release in a cytosol-mimicking environment","volume":"20","author":"Westarp","year":"2025","journal-title":"Discover Nano"},{"key":"10.1016\/j.ijpx.2026.100643_bb0745","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-023-00419-9","article-title":"The estimated annual financial impact of gene therapy in the United States","volume":"30","author":"Wong","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.ijpx.2026.100643_bb0750","article-title":"Binding-Mediated Formation of Ribonucleoprotein Corona for Efficient Delivery and Control of CRISPR\/Cas9","volume":"60","author":"Wu","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ijpx.2026.100643_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2024.08.019","article-title":"Enhanced delivery of CRISPR\/Cas9 system based on biomimetic nanoparticles for hepatitis B virus therapy","volume":"374","author":"Wu","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100643_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114501","article-title":"A matrix metalloproteinase-responsive hydrogel delivers dendritic cell-targeting nanoparticles for sustained antitumor immunity","volume":"390","author":"Wu","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100643_bb0765","doi-asserted-by":"crossref","DOI":"10.2196\/83709","article-title":"Global Research Trends and Hotspots in Gene Editing and Stem Cell Therapies for Neurodegenerative Diseases: Bibliometric and Visualization Analysis","volume":"15","author":"Xiang","year":"2026","journal-title":"Interact J. Med. Res."},{"key":"10.1016\/j.ijpx.2026.100643_bb0770","article-title":"Delivery of CRISPR\/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing","volume":"12","author":"Xiu","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ijpx.2026.100643_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.csbj.2020.08.031","article-title":"CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy","author":"Xu","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ijpx.2026.100643_bb0780","article-title":"Effective Delivery of the CRISPR\/Cas9 System Enabled by Functionalized Mesoporous Silica Nanoparticles for GFP-Tagged Paxillin Knock-In","volume":"4","author":"Xu","year":"2021","journal-title":"Adv. Ther. (Weinh)"},{"key":"10.1016\/j.ijpx.2026.100643_bb0785","article-title":"Nuclear-targeted CRISPR\/Cas delivery by using aptamer-modified polymer lipid nanoparticles","volume":"74","author":"Xu","year":"2026","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100643_bb0790","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.327","article-title":"Nanoparticles-induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models","author":"Xuan","year":"2023","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.ijpx.2026.100643_bb0795","article-title":"Nanoscale ATP-Responsive Zeolitic Imidazole Framework-90 as a General Platform for Cytosolic Protein Delivery and Genome Editing","volume":"141","author":"Yang","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpx.2026.100643_bb0800","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-024-03627-4","article-title":"Ultrasound-responsive nanoparticles for nitric oxide release to inhibit the growth of breast cancer","volume":"24","author":"Yang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijpx.2026.100643_bb0805","article-title":"Biodegradable zinc-based metallic materials: Mechanisms, properties, and applications","author":"Yang","year":"2026","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104404","article-title":"Pharmacokinetics and tumor delivery of nanoparticles","author":"Yuan","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0815","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2026.100643_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114598","article-title":"CD44-targeted lipid nanoparticles for enhanced CRISPR\/Cas9 delivery in cancer gene editing","volume":"391","author":"Zeng","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100643_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2025.138287","article-title":"Charge-engineered lipid nanoparticles with poly (\u03b3-glutamic acid) for improved CRISPR\/Cas9 genome editing","volume":"727","author":"Zhang","year":"2025","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ijpx.2026.100643_bb0830","article-title":"CES1-Triggered Liver-Specific Cargo Release of CRISPR\/Cas9 Elements by Cationic Triadic Copolymeric Nanoparticles Targeting Gene Editing of PCSK9 for Hyperlipidemia Amelioration","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijpx.2026.100643_bb0835","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301067120","article-title":"Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm","volume":"120","author":"Zheng","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijpx.2026.100643_bb0840","article-title":"Predicting the translation efficiency of messenger RNA in mammalian cells","author":"Zheng","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2018.07.019","article-title":"Nanoparticles Based on Poly (\u03b2-Amino Ester) and HPV16-Targeting CRISPR\/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy","volume":"26","author":"Zhu","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpx.2026.100643_bb0850","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02969-5","article-title":"Nanocarriers for intracellular delivery of proteins in biomedical applications: strategies and recent advances","author":"Zhu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100643_bb0855","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03182-8","article-title":"Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticles","volume":"23","author":"Zou","year":"2025","journal-title":"J. Nanobiotechnol."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:09:47Z","timestamp":1793030987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":172,"alternative-id":["S2590156726001635"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100643","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted Nanoparticle Delivery CRISPR\/Cas9: overcoming biological barriers, enhancing stability, and improving therapeutic precision","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100643"}}